SynthesisBioMed research international2026
The Association Between Serum α-Tocopherol and Pathogenesis of Multiple Sclerosis: A Systematic Review and Meta-Analysis of Case-Control Studies.
Synthesis in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The Association Between Serum α-Tocopherol and Pathogenesis of Multiple Sclerosis: A Systematic Review and Meta-Analysis of Case-Control Studies.BioMed research international · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundOxidative stress is a key pathological mechanism of multiple sclerosis (MS) and α-tocopherol is recognized as a primary chain-breaking antioxidant. This study is aimed at investigating the relationship between serum α-tocopherol and the pathogenesis of MS
methodsThis systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and the Joanna Briggs Institute (JBI) manual for evidence synthesis. Scopus, PubMed, Web of Science, and Embase were searched in March 2025. The risk of bias was evaluated using the critical appraisal tool developed by JBI. All statistical analyses were performed with comprehensive meta-analysis software (CMA3).
resultsOut of 506 records evaluated during the title/abstract screening phase, five case-control studies were included. Studies encompassed a total of 389 participants, comprising 211 individuals diagnosed with MS and 178 healthy controls. The levels of α-tocopherol were found to be lower in MS patients compared to the healthy group (standardized mean difference [SMD] = -1.17; 95% CI: -2.02, -0.31; p = 0.007, I DISCUSSION: Current evidence supports the possible association of serum α-tocopherol and MS pathogenesis; however, considering the restricted number of included studies (five papers), the retrospective nature of the studies, and substantial heterogeneity in the conducted quantitative synthesis, multicenter and large-scale prospective studies are recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.